Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model  by Cruz, Fernanda F. et al.
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We  hypothesized  that  bone  marrow-derived  mononuclear  cell  (BMDMC)  therapy  protects  the  lung  and
consequently  the  heart  in  experimental  elastase-induced  emphysema.  Twenty-four  female  C57BL/6  mice
were  intratracheally  instilled  with  saline  (C  group)  or porcine  pancreatic  elastase  (E group)  once  a week
during  4 weeks.  C  and  E  groups  were  randomized  into  subgroups  receiving  saline  (SAL)  or  male  BMDMCs
(2 ×  106, CELL)  intravenously  3  h  after  the  ﬁrst  saline  or elastase  instillation.  Compared  to  E-SAL  group,emodeling
tem cells
ardiovascular function
E-CELL  mice  showed,  at 5 weeks:  lower  mean  linear  intercept,  neutrophil  inﬁltration,  elastolysis,  collagen
ﬁber  deposition  in alveolar  septa  and  pulmonary  vessel  wall,  lung  cell  apoptosis,  right  ventricle  wall thick-
ness and  area,  higher  endothelial  growth  factor  and  insulin-like  growth  factor  mRNA  expressions  in lung
tissue,  and  reduced  platelet-derived  growth  factor,  transforming  growth  factor-,  and  caspase-3  expres-
sions. In conclusion,  BMDMC  therapy  was  effective  at  modulating  the  inﬂammatory  and  remodeling
processes  in  the  present  model  of  elastase-induced  emphysema.. Introduction
Chronic obstructive pulmonary disease (COPD), comprised of
mphysema and chronic bronchitis, is the fourth leading cause of
eath in the United States and thus a major public health concern
Mannino and Braman, 2007). Emphysema, deﬁned as irreversible
estruction of the alveoli, is associated with inﬂammation in the
irways and lung parenchyma (Snider, 1985). In addition to the
ell-known impact of emphysema on the lungs, extrapulmonary
ystemic effects have also been described (Agusti et al., 2003). In
his line, pulmonary hypertension, which results from destruc-
ion of the capillary network embedded in the alveolar walls, may
ead to cor pulmonale,  an alteration of the structure and function
f the right ventricle that signiﬁcantly contributes to the severity
nd mortality of emphysema (Fabbri et al., 2006, 2008). Although
ubstantial progress has been made in understanding many of the
∗ Corresponding author at: Laboratory of Pulmonary Investigation, Carlos Chagas
ilho Biophysics Institute, Federal University of Rio de Janeiro, Centro de Ciências
a  Saúde, Avenida Carlos Chagas Filho, s/n, Bloco G-014, Ilha do Fundão 21941-902,
io de Janeiro, RJ, Brazil. Tel.: +55 21 2562 6530; fax: +55 21 2280 8193.
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569-9048 © 2012 Elsevier B.V. Open access under the Elsevier OA license.molecular mechanisms underlying emphysema (Brusselle et al.,
2011; Churg et al., 2011), this knowledge has not translated into
effective therapies (Sutherland and Cherniack, 2004; Barnes and
Stockley, 2005; Rabe and Wedzicha, 2011). To date, antioxidant
and anti-inﬂammatory therapies yield only limited improvement
in lung function (Rabe and Wedzicha, 2011).
Adult bone marrow-derived stem cells are potent modu-
lators of immune responses, promoting cell proliferation and
re-epithelization of the injured lung (Yamada et al., 2004; Rojas
et al., 2005; Xu et al., 2007; Gupta et al., 2007; Abreu et al., 2011a).
Based on this assumption, several studies have shown beneﬁcial
effects of cell-based therapy in experimental emphysema induced
by cigarette smoke (Huh et al., 2011; Schweitzer et al., 2011), papain
(Zhen et al., 2008, 2010), as well as elastase (Shigemura et al.,
2006; Katsha et al., 2011). These effects have been attributed to
immunomodulation either from cytokine release or activation of
the endogenous immune system (Rojas et al., 2005; Rasmusson,
2006; Ortiz et al., 2007), since low level of bone marrow cell reten-
tion has been observed. Nevertheless, so far, no report has described
© 2012 Elsevier B.V. Open access under the Elsevier OA license.the impact of cell-based therapy not only on lung, but also on heart
in emphysema.
Therefore, the aim of this study was to test the hypothesis
that bone marrow-derived mononuclear cell (BMDMC) therapy
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Fig. 1. Schematic ﬂow chart (A) and timeline (B) of the study design. C: intratracheal
instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous injection ofF.F. Cruz et al. / Respiratory Physio
ay  act on inﬂammatory and remodeling processes, reducing lung
amage and thus improving cardiac function in a murine model
f pulmonary elastase-induced emphysema. For this purpose, we
nalyzed lung histology, elastic and collagen ﬁber content in the
lveolar septa and pulmonary vessel wall, the expression of growth
actors in lung tissue, and echocardiographic parameters.
. Material and methods
This study was approved by the Ethics Committee of the Carlos
hagas Filho Institute of Biophysics, Health Sciences Center, Federal
niversity of Rio de Janeiro (Number of study approval: IBCCF019).
ll animals received humane care in compliance with the “Princi-
les of Laboratory Animal Care” formulated by the National Society
or Medical Research and the “Guide for the Care and Use of Lab-
ratory Animals” prepared by the National Academy of Sciences,
SA.
.1. Extraction and characterization of bone marrow-derived
ononuclear cells
Bone marrow cells from 5 male C57BL/6 mice were ﬂushed from
he femurs and tibias with Dulbecco’s modiﬁed Eagle’s medium
DMEM). After a homogeneous cell suspension was achieved, cells
ere centrifuged (400 × g for 10 min), resuspended in DMEM and
dded to Ficoll-Hypaque. The isolated cells were counted in a
eubauer chamber with Trypan Blue for evaluation of viability.
aline or BMDMC  were slowly injected into the jugular vein. A small
liquot of mononuclear cells was used for immunophenotypic
haracterization of the injected cell population. Cell characteri-
ation was performed by ﬂow cytometry using antibodies CD45
leukocyte), CD34 (hematopoietic precursors), CD3, CD8, and CD4
T lymphocyte), CD14 (monocytes and macrophages), CD11b,
D29 and CD45- (non-hematopoietic precursors), all from BD Bio-
ciences, USA (Abreu et al., 2011a).
.2. Animal preparation and experimental protocol
Twenty-four female and ﬁve male C57BL/6 mice (20–25 g)
ere used in this study. The animals were kept under speciﬁc
athogen-free conditions in the animal care facility of Laboratory
f Pulmonary Investigation, Federal University of Rio de Janeiro.
Females were randomly assigned into control (C) and elastase-
nduced emphysema (E) groups. In C group, sterile saline solution
0.9% NaCl) was intratracheally (i.t.) instilled (50 l), while in E
roup, mice received porcine pancreatic elastase i.t. (0.1 UI, 50 l
f saline solution, PPE – Sigma Chemical Co., St. Louis, MO,  USA).
aline and PPE were administered once a week during 4 weeks. For
ntratracheal instillation, mice were anesthetized with sevoﬂurane.
 midline cervical incision (1 cm)  was made to expose the trachea,
nd saline or PPE were instilled using a bent 27-gauge tuberculin
eedle. The cervical incision was closed with 5.0 silk suture and the
ice returned to their cage.
Three hours after the ﬁrst instillation of saline or PPE, animals
ere further randomized into subgroups receiving saline solution
0.9% NaCl, 50 l, SAL) or BMDMC  (2 × 106 cells diluted in 50 l
aline solution, CELL) through the left jugular vein (Fig. 1).
.3. Echocardiography
For acquisition of the images, VEVO 770 form Visual Sonics
Canada) coupled to a 30 MHz  transducer was used. Images were
btained from the subcostal and parasternal views. M-mode images
howed right ventricular muscle thickness. Short and long-axis B-
imensional views of both ventricles were acquired at the level
f the papillary muscles to obtain left and right ventricular areas,saline, CELL: intravenous injection of BMDMC  (2 × 106) 3 h after the ﬁrst instillation
of  saline or PPE. All data were analyzed at day 28.
as well as left ventricular cardiac output and ejection fraction by
Simpson’s method (Lang et al., 2006). All parameters followed
the recommendations of the American and European Societies of
echocardiography.
2.4. Lung histology
One week after the last intratracheal instillation of saline or PPE,
animals were sedated (diazepam 1 mg  ip), anesthetized (thiopental
sodium 20 mg/kg ip), tracheotomized, paralyzed (vecuronium bro-
mide, 0.005 mg  kg iv), and ventilated with a constant ﬂow ventilator
(Samay VR15; Universidad de la Republica, Montevideo, Uruguay)
with the following parameters: frequency of 100 breaths/min, tidal
volume (VT) of 0.2 ml, and fraction of inspired oxygen of 0.21. The
anterior chest wall was  surgically removed and a positive end-
expiratory pressure of 2 cm H2O applied.
A laparotomy was  performed and heparin (1000 IU) was intra-
venously injected in the vena cava. The trachea was  clamped
at end-expiration, and the abdominal aorta and vena cava were
sectioned, yielding a massive hemorrhage that quickly killed the
animals. The right lung was  then removed, ﬁxed in 3% buffered
formaldehyde and parafﬁn embedded. Four-m-thick slices were
cut and stained with hematoxylin-eosin. Lung morphometry anal-
ysis was  performed with an integrating eyepiece with a coherent
system consisting of a grid with 100 points and 50 lines (known
length) coupled to a conventional light microscope (Olympus BX51,
Olympus Latin America-Inc., Brazil). The volume fractions of the
lung occupied by collapsed alveoli (alveoli with rough or pli-
cate walls), normal pulmonary areas or hyperinﬂated structures
(alveolar ducts, alveolar sacs, or alveoli, all with maximal chord
length in air >120 m)  were determined by the point-counting
technique (Weibel, 1990) across 10 random, non-coincident micro-
scopic ﬁelds. Brieﬂy, points falling on collapsed, normal pulmonary
areas or hyperinﬂated structures were counted and divided by the
total number of points in each microscopic ﬁeld.
Enlargement of air spaces was  evaluated using mean lin-
ear intercept measurement (Lm) (Dunnill, 1964). The fraction
of neutrophils and mononuclear cells was also evaluated. Colla-
gen (Picrosirius-polarization method) and elastic ﬁbers (Weigert’s
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esorcin fuchsin method with oxidation) (Fullmer et al., 1974) were
uantiﬁed in alveolar septa and pulmonary vessel wall.
.5. Transmission electron microscopy
Three slices of 2 mm ×2 mm  ×2 mm  were cut from three differ-
nt segments of the left lung and ﬁxed [2.5% glutaraldehyde and
hosphate buffer 0.1 M (pH = 7.4)] for electron microscopy (JEOL
010 Transmission Electron Microscope, Tokyo, Japan) analysis. For
ach lung electron microscopy image (20/animal), the following
lterations were analyzed: (a) alveolar-capillary membrane dam-
ge, (b) type II pneumocyte lesion, (c) endothelial cell lesion, (d)
eutrophil inﬁltration, (e) elastic ﬁber breakdown, (f) collagen ﬁber
eposition, and (g) apoptotic cells (Abreu et al., 2011a).  The patho-
ogic ﬁndings were graded according to a 5-point semi-quantitative
everity-based scoring system as: 0 = normal lung parenchyma,
 = changes in 1–25%, 2 = changes in 26–50%, 3 = changes in 51–75%,
nd 4 = changes in 76–100% of examined tissue.
.6. Apoptosis assay of lung
Terminal deoxynucleotidyl transferase biotin-dUTP nick end
abeling staining was used to assay cellular apoptosis (Oliveira et al.,
009). Ten ﬁelds per section from the regions with cell apoptosis
ere examined at a magniﬁcation of ×400. A 5-point semi-
uantitative severity-based scoring system was  used to assess
he degree of apoptosis: 0 = normal lung parenchyma; 1 = 1–25%;
 = 26–50%; 3 = 51–75%; and 4 = 76–100% of examined tissue.
.7. Y Chromosome DNA detection
Quantiﬁcation of murine Y chromosome in lung tissue was
chieved by quantitative real-time polymerase chain reaction
PCR). Brieﬂy, DNA was puriﬁed in a 600 l solution of 0.2%
odium dodecyl sulfate (SDS)/proteinase K (300 g/ml), extracted
ith an equal volume of phenol/chloroform/isoamyl alcohol, and
entrifuged for 15 min  at 14,000 rpm. The aqueous phase was trans-
erred to a new tube. DNA was precipitated with 2 volumes of
thanol 100% and centrifuged for 15 min  at 14,000 rpm. DNA was
esuspended and quantiﬁed in a nanodrop spectrophotometer. 5 ng
f DNA was used in a real-time PCR reaction with SYBR Green
etection kit run in 7000-sequence detection system thermocy-
ler according to manufacturer instructions (Applied Biosystems,
oster City, CA). The following PCR primers were used: forward
′-TCA TCG GAG GGC TAA AGT G-3′; and reverse 5′-CAA CCT TCT
CA GTG GGA C-3′. Primers sequences were deﬁned using primer3
oftware based on Mus  musculus sex-determining region of Chr
 (Sry) gene, gene bank accession number: NM 011564 (National
nstitutes of Health, NIH, Bethesda, USA). These primers amplify an
8 bp product. The relative amount of total DNA was calculated as
 ratio (2-Ct)  of Sry and glyceraldehyde-3-phosphate dehydroge-
ase (GAPDH). Primers for GAPDH – Forward: 5′-CCA CCA ACT GCT
AG CCC-3′ and reverse: 5′-GAC ACC TAC AAA GAA GGG TCC A-3′,
45 bp.
.8. Expression of growth factors and caspase-3
In order to evaluate the mechanisms related to lung remodel-
ng, quantitative real-time reverse transcription (RT) polymerase
hain reaction (PCR) was performed to measure the expression
f transforming growth factor (TGF)-,  platelet derived growth
actor (PDGF), vascular endothelial growth factor (VEGF), insulin-
ike growth factor (IGF), and caspase-3 genes. Central slices of left
ungs were cut, collected in cryotubes, quick-frozen by immersion
n liquid nitrogen, and stored at −80 ◦C. Total RNA was  extracted Neurobiology 182 (2012) 26– 36
from the frozen tissues, using the Trizol reagent (Invitrogen, Carls-
bad, CA) according to the manufacturer’s recommendations. RNA
concentration was  measured by spectrophotometry in Nanodrop®
ND-1000. First-strand cDNA was synthesized from total RNA using
M-MLV  Reverse Transcriptase Kit (Invitrogen, Carlsbad, CA). PCR
primers for target gene were purchased (Invitrogen, Carlsbad, CA).
The following primers were used: VEGF [5′-cca cga cag aag gag
agc a-3′ (forward) and 5′-aat cgg acg gca gta gct t-3′ (reverse)],
TGF- [5′-ATA CGC CTG AGT GGC TGT C-3′ (forward) and 5′-GCC
CTG TAT TCC GTC TCC T-3′ (reverse)], PDGF [5′-TCG AAG TCA GAT
CCA CAG CA-3′ (forward) and 5′-CTT GTC TCC AAG GCA TCC TC-
3′ (reverse)], IGF [5′-CTG GTG GAT GCT CTT CAG TTC-3′ (forward)
and 5′-CCA GTC TCC TCA GAT CAC AGC-3′ (reverse)], and caspase-3
[5′-TAC CGG TGG AGG CTG ACT-3′ (forward) and 5′-GCT GCA AAG
GGA CTG GAT-3′ (reverse)]. Relative mRNA levels were measured
with a SYBR green detection system using ABI 7500 Real-Time PCR
(Applied Biosystems, Foster City, CA). All samples were measured
in triplicate. The expression of each gene was calculated as a ratio
compared with the reference gene, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) [5′-AAC TTT GGC ATT GTG GAA GG-3′
(forward) and 5′-GTC TTC TGG GTG GCA GTG AT-3′ (reverse)] and
expressed as fold change relative to C-SAL.
2.9. Statistical analysis
Two-way ANOVA followed by Tukey’s test was used to com-
pare parametric data. For non-parametric data, two-way ANOVA
on ranks followed by Dunn’s post hoc test was  selected. The signif-
icance level was  always set at 5%. Parametric data were expressed
as mean ± standard error mean (SEM), while non-parametric data
were expressed as median (interquartile range). All tests were per-
formed using SigmaStat 3.1 (Jandel Corporation, San Raphael, CA,
USA).
3. Results
The pool of intravenously injected BMDMC  was  character-
ized by ﬂow cytometry showing the following subpopulations:
total lymphocytes (CD45+/CD11b−/CD29−/CD34−  = 29.7%), T
lymphocytes (CD45+/CD3+/CD34−= 5.4%), T helper lymphocytes
(CD3+/CD4+/CD8− = 2.4%), T cytotoxic lymphocytes (CD3+/CD4−/
CD8+ = 2.3%), monocytes (CD45+/CD29+/CD11b−/CD34−/CD3− =
4.9%), neutrophils (CD45+/CD11b+/CD34−/CD29−/CD14−/
CD34−/CD3− = 50.1%), hematopoietic progenitors (CD34+/
CD45+ = 0.3%), and other progenitors cells (CD45− = 3.8%).
Echocardiography showed that E-SAL had greater right ven-
tricular wall thickness and right ventricular area compared to
C-SAL; BMDMC  administration signiﬁcantly reduced these param-
eters (Table 1, Fig. 2). There was no difference between any groups
regarding left ventricular repercussions (area, cardiac output or
ejection fraction).
Morphometric examination of lungs demonstrated that the
mean linear intercept, the fraction area of alveolar collapse, hyper-
inﬂation, mononuclear cells and neutrophils in lung tissue, as well
as collagen ﬁber content in alveolar septa and pulmonary vessel
wall were higher in E-SAL than C-SAL group. Elastic ﬁber con-
tent was  lower in E-SAL than C-SAL, and elastic ﬁber breakdown
was  more evident in E-SAL (Table 2, Fig. 3). BMDMC therapy min-
imized the fraction area of alveolar collapse, hyperinﬂation, and
neutrophil inﬁltration, the amount of collagen ﬁber in the alve-
olar septa and pulmonary vessel wall (Table 2, Fig. 4). It also
prevented changes in the fraction area of mononuclear cells and
elastic ﬁber content in the alveolar septa and pulmonary vessel
wall.
F.F. Cruz et al. / Respiratory Physiology & Neurobiology 182 (2012) 26– 36 29
Table  1
Echocardiographic analysis.
Groups C E
SAL CELL SAL CELL
Right ventricular wall thickness (mm)  0.22 ± 0.05 0.30 ± 0.06 0.57 ± 0.06* 0.41 ± 0.07* ,**
Right ventricular area (mm2) 10.02 ± 0.17 10.15 ± 0.13 10.97 ± 0.34* 10.38 ± 0.15* ,**
Left ventricular area (mm2) 14.99 ± 0.75 16.01 ± 0.98 15.21 ± 0.84 15.75 ± 1.01
Cardiac  output (ml) 15.35 ± 4.35 15.49 ± 2.89 15.25 ± 3.72 15.98 ± 1.79
Ejection  fraction (%) 68.45 ± 3.50 62.59 ± 6.11 65.30 ± 4.45 61.84 ± 7.13
Values are mean ± SEM of 6 animals in each group. C: intratracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL:
intravenous injection of BMDMC  (2 ×106) 3 h after the ﬁrst instillation of saline or PPE.
* Signiﬁcantly different from C-SAL (p < 0.05).
** Signiﬁcantly different from E-SAL (p < 0.05).
Fig. 2. Short-axis B-dimensional views of both ventricles, acquired at the level of the papillary muscles. LV: left ventricle, RV: right ventricle. C: intratracheal instillation of
saline,  E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL: intravenous injection of BMDMC  (2 × 106) 3 h after the ﬁrst instillation of saline or PPE.
Table  2
Lung histology.
Groups C E
SAL CELL SAL CELL
Normal (%) 96.9 ± 0.8 93.4 ± 1.8 53.9 ± 6.9* 80.9 ± 4.1* ,**
Collapse (%) 3.1 ± 1.3 6.6 ± 1.8 21.2 ± 2.3* 14.1 ± 3.6* ,**
Hyperinﬂation (%) 0 ± 0 0 ± 0 24.9 ± 4.7* 5.0 ± 1.3* ,**
Mean linear intercept (Lm) 38.9 ± 1.8 39.8 ± 2.3 68.5 ± 1.1* 48.5 ± 1.0* ,**
Mononuclear cells (%) 34.8 ± 2.3 36.5 ± 0.1 44.7 ± 1.4* 34.9 ± 1.7
Neutrophils (%) 0.5 ± 0.3 2.3 ± 0.1* 5.1 ± 0.5* 2.4 ± 0.3* ,**
Collagen ﬁber in alveolar septa (%) 24.6 ± 1.0 25.3 ± 1.5 52.6 ± 3.8* 32.6 ± 2.2* ,**
Elastic ﬁber in alveolar septa (%) 10.4 ± 0.3 11.2 ± 1.1 9.5 ± 0.4* 11.3 ± 1.1
Collagen ﬁber in pulmonary vessel wall (%) 13.0 ± 1.1 14.9 ± 1.2 23.8 ± 3.7* 16.6 ± 1.9* ,**
Elastic ﬁber in pulmonary vessel wall (%) 46.2 ± 2.4 47.0 ± 1.9 30.4 ± 3.3* 41.6 ± 2.2
Values are mean ± SEM of 6 animals in each group. All values were computed in ten random, non-coincident ﬁelds per mice. C: intratracheal instillation of saline, E:
intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL: intravenous injection of BMDMC  (2 × 106) 3 h after the ﬁrst instillation of saline or PPE.
* Signiﬁcantly different from C-SAL (p < 0.05).
** Signiﬁcantly different from E-SAL (p < 0.05).
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ntratracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intraven
nstillation of saline or PPE. Note elastic ﬁber breakdown (arrows).
E-SAL group presented increased number of lung apoptotic cells
median [25th–75th interquartile range]: 2.0 [1.75–2.25]) com-
ared to C-SAL (0 [0–0.25]. BMDMC  therapy led to a reduction
n the number of lung apoptotic cells (1 [0.75–1]) (p = 0.03). Simi-
arly, caspase-3 expression was lower in E-CELL compared to E-SAL
Fig. 5).
Electron microscopy showed degeneration of the alveolar capil-
ary membrane and damage to type II pneumocytes and endothelial
ells, as well as increased neutrophil inﬁltration, elastic ﬁber break-
own and collagen ﬁber deposition in E-SAL group (Table 2, Fig. 6).
n Fig. 6 (E-SAL), epithelial and endothelial cells were not present.eosin (HE) and Weigert’s resorcin fuchsin method with oxidation (elastic ﬁbers). C:
jection of saline, CELL: intravenous injection of BMDMC  (2 × 106) 3 h after the ﬁrst
BMDMC  attenuated all these ultrastructural changes and yielded
multinucleated cells and type II pneumocytes with large hyper-
plasia of lamellar bodies. Additionally, epithelial and endothelial
cells were noted around the interstitium. Cell therapy also miti-
gated airway damage, reducing basement membrane irregularity
and fragmentation, as well as disorganization and detachment of
the airway epithelial cell layer (Table 3, Fig. 6).Y chromosome DNA was  not detected in lung tissue at 5 weeks
in cell-treated groups.
TGF-, PDGF, and IGF mRNA expressions in lung tissue were
higher, while VEGF expression was lower in E-SAL compared to
F.F. Cruz et al. / Respiratory Physiology & Neurobiology 182 (2012) 26– 36 31
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ation  of saline, E: intratracheal instillation of PPE, SAL: intravenous injection of sali
r  PPE.
-SAL. BMDMC  administration led to an increase in IGF and VEGF
RNA expressions, and a reduction in TGF- and PDGF expressions
Fig. 7).. Discussion
In the present murine model of pulmonary elatase-induced
mphysema, early intravenous BMDMC  therapy led to: (1)ined with Picrosirius-polarization method (collagen ﬁbers). C: intratracheal instil-
LL: intravenous injection of BMDMC  (2 × 106) 3 h after the ﬁrst instillation of saline
reduction in mean linear intercept, fraction area of alveolar collapse
and hyperinﬂation; (2) reduction in the number of mononuclear
cells and neutrophils and collagen ﬁber deposition in lung tissue;
(3) increase in elastic ﬁbers in the alveolar septa; (4) decrease in air-
way  epithelium and alveolar-capillary membrane damage as well
as elastic ﬁber breakdown; (5) reduction in the degree of lung apop-
totic cells and caspase-3 expression, and (6) improvement of right
ventricular wall thickness and right ventricular area followed by
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Fig. 5. (A) Representative photomicrographs showing TUNEL-positive cells. Note apoptotic cells (brown nucleus cells). (B) Real-time polymerase chain reaction of caspase-3.
Values  are mean ± SEM of 5 animals in each group. *Signiﬁcantly different from C-SAL (p < 0.05). †Signiﬁcantly different from E-SAL (p < 0.05). C: intratracheal instillation of
saline,  E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL: intravenous injection of BMDMC  (2 × 106) 3 h after the ﬁrst instillation of saline or PPE.
Table  3
Semi-quantitative analysis of lung electron microscopy.
Groups C E
SAL CELL SAL CELL
Alveolar capillary membrane damage 0 (0–0) 0 (0–0) 3 (2.75–3.25)* 1 (1–2)
Type  II pneumocyte damage 0 (0–0) 0 (0–0) 2 (1.75–2.25)* 0 (0–1)
Endothelial cell damage 0 (0–0) 0 (0–0) 2 (1.75–3)* 0 (0–1)
Neutrophil inﬁltration 0 (0–0) 0 (0–0) 3 (2.75–4)* 1 (0.75–2)
Elastic ﬁber breakdown 0 (0–0) 0 (0–0) 3 (2.75–4)* 1 (0.75–1.25)
Collagen ﬁber deposition 0 (0–0) 0 (0–0) 3 (2–3)* 1 (0–1)
Values are median (25th–75th percentile) of ﬁve mice in each group. Lung tissue score was assigned independently by two investigators. Pathologic ﬁndings were graded
according to a 5-point semi-quantitative severity-based scoring system: 0 = normal lung parenchyma, 1 = changes in 1–25%, 2 = changes in 26–50%, 3 = changes in 51–75%,
and  4 = changes in 76–100% of the examined structure. C: intratracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous injection of saline, CELL:
intravenous injection of BMDMC  (2 ×106) 3 h after the ﬁrst instillation of saline or PPE.
* Signiﬁcantly different from C-SAL (p < 0.05).
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Fig. 6. Electron microscopy of terminal bronchiole (right panels) and lung parenchyma (left panels). C: intratracheal instillation of saline, E: intratracheal instillation of PPE,
SAL:  intravenous injection of saline, CELL: intravenous injection of BMDMC (2 × 106) 3 h after the ﬁrst instillation of saline or PPE. Airspace (AS), basement membrane (BM),
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nterstitial cell, large lamellar bodies (arrowheads). Photomicrographs are represen
 reduction in collagen ﬁbers in lung arterial vessels. Our ﬁndings
uggest that the lung and heart may  be protected by a mechanism
inked to a balance between growth factors.
In the present study, emphysema was induced by mul-
iple intratracheal instillations of porcine pancreatic elastase.
his model, initially described in NMRI mice (Luthje et al.,
009), leads to lung, cardiovascular, and systemic impairment
Antunes and Rocco, 2011), and induced lung and cardiovas-
ular damage in our C57BL/6 mice. Moreover, this method
f emphysema induction yields lengthy progressive inﬂam-
atory and remodeling processes, in addition to alveolar
estruction.neumocytes (PII), absence of epithelial and endothelial cells (arrows) around the
 of data obtained from lung sections derived from ﬁve animals.
The present study is the ﬁrst to demonstrate the protective
effects of early BMDMC  administration to the lung and heart in
experimental pulmonary elastase-induced emphysema. To identify
this homing of bone marrow cells to the lung parenchyma, we used
PCR of Y chromosome-speciﬁc sequences. However, Y chromo-
some DNA was not detected in lung tissue at day 28 in cell-treated
groups, suggesting that the beneﬁts we observed probably result
from paracrine effects. In this context, a recent study showed that
that bone marrow cell therapy improved smoke-induced emphy-
sema through paracrine effects rather than stem cell engraftment,
and reported that cell-free conditioned media of MSC  (MSC-CM)
also induced repair (Huh et al., 2011).The injection of BMDMC  even
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Fig. 7. Real-time polymerase chain reaction of growth factors. VEGF: vascular endothelial growth factor, PDGF: platelet derived growth factor, TGF-: transforming growth
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ifferent  from C-SAL (p < 0.05). †Signiﬁcantly different from E-SAL (p < 0.05).
n normal lungs led to neutrophil increase in lung tissue, with no
unctional effects. This increment may  be attributed to: presence of
eutrophils in the pool of BMDMC  and/or recruitment of these cells
y chemoattractive stimuli (Araújo et al., 2010; Prota et al., 2010;
breu et al., 2011a; Maron-Gutierrez et al., 2011).
Several studies have reported that circulating precursor cells
re reduced (Bonsignore et al., 2006; Huertas et al., 2010), and that
EGF-dependent precursor cell mobilization is impaired (Hattori
t al., 2001) in human COPD. In this line, the administration of
xogenous BMDMC  in the current study might have contributed
o the reduction of airway epithelial cell damage, tissue remodel-
ng and inﬂammatory processes by increasing the available pool
f circulating precursor cells. We  demonstrated that early BMDMC
dministration led to less hyperinﬂation and collapsed areas as well
s inﬂammatory cell inﬁltration in the lung parenchyma, reduced
mall airways collagen deposition, and elastic ﬁber preservation.
his is in agreement with a recent report that mechanical force-
nduced failure of the locally weakened collagen is correlated to
tructural changes in the lung undergoing heterogeneous conse-
uences of elastase injury (Hamakawa et al., 2010).
Ultrastructural analysis using electron microscopy revealed
igher preservation of endothelial cells, type II pneumocyte and
asement membrane, associated with reduction of collagen ﬁber
eposition and elastic ﬁber breakdown. Besides, several typical
eatures of regenerative processes, such as enlarged type II pneu-
ocytes with augmented lamellar bodies, as well as the presence
f multinucleated and undifferentiated cells in lung parenchyma
ere observed in the E-CELL group, suggesting that BMDMC  may
odulate elastase injury and play an important role in the repair
f damaged areas. However, the exact mechanisms responsible
or cell restoration remain unclear. It has been suggested that
hese multinucleated cells could be the result of a fusion between
acrophages and BMDMCs, or between macrophages and injured
pithelial cells (Krause, 2008). Additionally, it has been described
hat macrophages behave in vitro as stem cell attractors. Once at
he site of injury, the ability of precursor cells to reconstitute thetracheal instillation of saline, E: intratracheal instillation of PPE, SAL: intravenous
tion of saline or PPE. Values are mean ± SEM of 5 animals in each group. *Signiﬁcantly
damaged tissues depends on the signals generated in situ by the
macrophages (Lolmede et al., 2009).
Besides their proven plasticity, most beneﬁcial effects of stem
cells have been attributed to paracrine effects, that is, a capac-
ity of modulating cytokines and growth factor synthesis without
being present at the injury site (Abreu et al., 2011b; Doorn et al.,
2011). Paracrine effects have been demonstrated in several mod-
els of lung diseases, including emphysema (Shigemura et al., 2006;
Zhen et al., 2010; Huh et al., 2011; Schweitzer et al., 2011), and
appear to be mediated by mainly VEGF, KGF, and cytokines (Zhen
et al., 2010). There is evidence that the impairment of this sig-
naling pathway is intrinsically connected with the pathogenesis
of emphysema, leading to epithelial and endothelial cell apoptosis
and protease/antiprotease imbalance (Taraseviciene-Stewart and
Voelkel, 2008; Huertas and Palange, 2011). Similarly, in the present
study, elastase induced apoptosis through high mRNA expression
of the pro-apoptotic caspase-3. The protease also hampered the
expression of VEGF, while BMDMC  therapy yielded an increase in
mRNA expression of VEGF. VEGF is known to stimulate endothe-
lial and type II cell growth and survival by binding VEGF receptor
2 (Fehrenbach et al., 1999), supporting a lower degree of apo-
ptosis and ultrastructural regenerative process as observed in the
E-CELL group. We  demonstrated that BMDMCs were able to pre-
vent the increase in PDGF and TGF- mRNA expressions at day
28, which is in accordance with the reduced collagen ﬁber depo-
sition observed in the E-CELL group, since inhibition of PDGF has
been reported to prevent ﬁbrosis (Abdollahi et al., 2005). In this
line, TGF- is a potent inducer of collagen production by ﬁbrob-
lasts and myoﬁbroblasts, whereas the most important effect of
PDGF is as a mitogen for these cells, even though it also enhances
collagen production (Hoyle et al., 1999; Morty et al., 2009). Con-
versely, BMDMCs yielded an increase in IGF expression, a growth
factor associated with re-epithelization (Yamashita et al., 2005)
and anti-apoptotic (Sadat et al., 2007) and angiogenic (Oskowitz
et al., 2011) processes, suggesting that this may  be the mecha-
nism through which BMDMCs warrant the preservation of alveolar
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pithelial and endothelial cells. Regarding the absence of donated
ells in receptor tissue, our results also point to a paracrine action of
MDMCs, reducing airway, lung parenchyma as well as pulmonary
essel wall damage. Additionally, our protocol of elastase-induced
mphysema led to cardiovascular damage, which was attenuated
y BMDMC  therapy. In this line, echocardiographic measurements
howed a reduction in wall thickness and area of right ventricle
ssociated with a reduction in the amount of collagen and elastic
ber in pulmonary vessel wall after BMDMC  administration. In this
ontext, Yoshida and colleagues described similar improvement
f pulmonary arterial hypertension through VEGF upregulation
Yoshida et al., 2009). Pulmonary arterial hypertension induces
orphological changes in right ventricle, a pathologic condition
nown as cor pulmonale.  This disorder may  occur as a result of
arious combined mechanisms, including loss of pulmonary vas-
ular capacity due to parenchymal destruction (Liebow, 1959),
ulmonary arterial vasoconstriction due to hypoxemia and respi-
atory acidosis (Barbera et al., 2003), ﬁbrotic lung injury (Cottin
t al., 2005), pulmonary hyperinﬂation with elevated intrathoracic
ressure (Jorgensen et al., 2007), and atherosclerosis (Arunachalam
t al., 2010). All these factors promote progressive blood ﬂow
estriction to pulmonary vascular bed, leading to right ventricu-
ar hypertrophy. Huh and colleagues have reported that BMDMCs
lleviate pulmonary hypertension in a cigarette smoke-induced
mphysema model, inhibiting muscularization in small pulmonary
essels and stimulating VEGF-induced angiogenesis (Huh et al.,
011). Similarly, in the current study, a right cardiac dysfunction
as also detected in E-SAL, which was signiﬁcantly minimized in
he E-CELL group. This behavior was accompanied by a marked
eduction in collagen ﬁber content in airways, pulmonary wall
essels, and alveolar septa, and associated with a lower mRNA
xpression of TGF- and PDGF. Severe COPD leads to cor pulmonale
ombined with secondary reduction in left ventricular ﬁlling, stroke
olume and cardiac output (Barr et al., 2010). Nevertheless, no left
entricular dysfunction was found in our study, which implies that
he present murine model of elastase-induced emphysema did not
each such high severity and/or did not have sufﬁcient time to
evelop.
The present study has some limitations: (1) BMDMC  were
njected 3 h after ﬁrst elastase administration. Consequently, more
tudies should be performed to analyze BMDMC  effects after the
njury is established; (2) all data were analyzed at 5 weeks. There-
ore, the time course analysis following BMDMC  therapy was not
erformed, limiting the understanding of the early effects of cell
herapy; (3) Y chromosome DNA was also studied only at 5 weeks
n cell-treated groups, and the behavior of BMDMC  immediately
fter injection was not analyzed; (4) elastolysis was not evaluated
sing casein and elastin zymography but electron microscopy, and
5) we were not able to determine whether BMDMC had a direct
eneﬁcial effect on the heart or an indirect beneﬁt mediated by
mprovement of lung injury. Therefore, future studies analyzing
eart data, such as right ventricular weight, collagen ﬁber content,
poptosis, and cytokine/growth factor expressions will be required
o better elucidate the direct effect of elastase or cell therapy on the
eart.
In conclusion, in the present murine model of pulmonary
lastase-induced emphysema, BMDMC  therapy was  effective to
revent lung and cardiovascular damage. These beneﬁcial effects
ight be attributed to paracrine effects modulating the expression
f growth factors involved in the pathogenesis of emphysema.cknowledgements
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